𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

✍ Scribed by Barreiro-de Acosta, M. (author);García-Bosch, O. (author);Souto, R. (author);Mañosa, M. (author);Miranda, J. (author);García-Sanchez, V. (author);Gordillo, J. (author);Chacon, S. (author);Loras, C. (author);Carpio, D. (author);Maroto, N. (author);Menchén, L. (author);Rojas-Feria, M. (author);Sierra, M. (author);Villoria, A. (author);Marin-Jimenez, I. (author)

Book ID
112101167
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
950 KB
Volume
18
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab or cyclosporine as rescue the
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study
✍ Mats Sjöberg; Andrea Walch; Mina Meshkat; Anders Gustavsson; Gunnar Järnerot; Ha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Background: Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives. Methods: Outcome of rescue therapy was retrospectively studied in two cohorts of pati